Yasuhiro Hida

Also affiliated with Fujita Health University Hospital

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “SlicerPIT: software development and implementation for planning and image-guided therapy in photoimmunotherapy”.

SlicerPIT: software development and implementation for planning and image-guided therapy in photoimmunotherapy

International Journal of Clinical Oncology(2024)10.1007/s10147-024-02516-0

N/A

0.312DataRank · unranked

7 citations

Satoshi Kano, Masanobu Suzuki, Seijiro Hamada, Hiroshi Idogawa, Nayuta Tsushima +6 more

Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy

Breast Cancer Research(2021)10.1186/s13058-021-01423-w

N/A

0DataRank · unranked

54 citations

Nako Maishi, Dorcas A. Annan, Marian F. Young, Hirofumi Morimoto, Masahiro Morimoto +4 more

Inhibition of Stromal Biglycan Promotes Normalization of the Tumor Microenvironment and Enhances Chemotherapeutic Efficacy

Research Square(2021)10.21203/rs.3.rs-142861/v1

N/A

0DataRank · unranked

0 citations

Nako Maishi, Dorcas A. Annan, Marian F. Young, Hirofumi Morimoto, Masahiro Morimoto +4 more